by Kazeem Olalekan

The following are some of the latest important updates from the newly April 2014 release of the BNF and BNFc:

 

Interchangeability of oral mesalazine preparations - BNF & BNFc


 

Metoclopramide: risk of neurological adverse effects - BNFc


 

Risk of venous thromboembolism events (VTE) with combined hormonal contraceptives


 
There are others: Do look at the BNFand BNFc websites
 

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.